$0.69
-0.02 (-3.44%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+5,239.6% upside
Low Target
$29.06
Average Target
$36.71
High Target
$43.55
Current Price
$0.69
Current
$0.69
$0.69
Target
$36.71
$36.71
$29.06
$36.71 avg
$43.55
Scenario Analysis
Bear Case
$29.06
4,126.9%
Low target
Base Case
$36.71
+5,239.6%
Avg target
Bull Case
$43.55
+6,234.5%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$7.20
-90.5% from high
52-Week Low
$0.46
+49.3% from low
Target vs 52W High
$36.71
+409.9% vs high
Next Earnings Report
Aug 18, 2026
7d
until earnings
EPS Est: $-0.29
Earnings in 7 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +12.2% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +15.5% |
| MRK | Buy | 36 | 69% | $159.27 | +23.9% |
| PFE | Hold | 36 | 39% | $33.90 | +26.7% |
| BMY | Hold | 35 | 40% | $174.50 | +169.6% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -36.1% |
| ZTS | Hold | 24 | 54% | $209.87 | +188.8% |